Sign In
Buy BMRN
$54.66
+1.34 (+2.51%)
At Close: Jun 03, 2026
BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:06am, Tuesday, 22'nd Oct 2024
BioMarin (BMRN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock
10:51am, Thursday, 17'th Oct 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
BioMarin to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Tuesday, October 29, 2024, at 4:30pm ET
08:30am, Wednesday, 16'th Oct 2024
SAN RAFAEL, Calif. , Oct. 16, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a conf
3 Oversold Stocks with Big RSI Rebound Potential
09:09am, Thursday, 03'rd Oct 2024
Everybody loves finding a bargain or getting a good deal, and it's no different when it comes to stocks. One of the most popular technical indicators for helping investors find these is the Relative S
3 Reasons Why Growth Investors Shouldn't Overlook BioMarin (BMRN)
01:46pm, Tuesday, 01'st Oct 2024
BioMarin (BMRN) is well positioned to outperform the market, as it exhibits above-average growth in financials.
BMRN or MYGN: Which Is the Better Value Stock Right Now?
12:46pm, Tuesday, 01'st Oct 2024
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with BioMarin Pharmaceutical (BMRN) and Myriad Genetics (MYGN). But which of these two companies is the best option
Down -22.94% in 4 Weeks, Here's Why You Should You Buy the Dip in BioMarin (BMRN)
10:36am, Tuesday, 01'st Oct 2024
BioMarin (BMRN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates
Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term
10:51am, Monday, 30'th Sep 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
BioMarin Stands Firm on 2027 Revenue Target Amid Ascendis Competition, Goldman Sachs Analyst Remains Bullish
03:50pm, Wednesday, 25'th Sep 2024
Last week, Ascendis Pharma A/S ASND released topline data on Monday from a trial that included 84 children with achondroplasia, a genetic disorder that causes dwarfism and disproportionate short stat
Results from Ongoing CANOPY Clinical Program for VOXZOGO Showcase Impact of C-Type Natriuretic Peptide (CNP) as Master Regulator of Growth-Related Development Across Multiple Genetic Skeletal Conditio
Ascendis Challenges BioMarin, But Market Response Seems Excessive
05:15pm, Tuesday, 17'th Sep 2024
Ascendis' TransCon CNP showed similar efficacy to BioMarin's Voxzogo, but offers once-weekly dosing, potentially improving patient adherence. The achondroplasia market is significant, with potential a
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock
10:51am, Friday, 13'th Sep 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
BioMarin Posts '27 Biz View, Outlines Growth Plans for Next 10 Years
12:26pm, Thursday, 05'th Sep 2024
BMRN divulges ambitious plans for business growth over the next 10 years. It expects yearly sales to grow at a mid-teen rate through 2034.
BioMarin Holds Investor Day; Provides New Corporate Strategy and Introduces 2027 Financial Guidance
01:00pm, Wednesday, 04'th Sep 2024
NEW YORK , Sept. 4, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) hosted an Investor Day earlier today, where President and Chief Executive Officer Alexander Hardy and other members
Why Is BioMarin (BMRN) Up 5.4% Since Last Earnings Report?
12:35pm, Wednesday, 04'th Sep 2024
BioMarin (BMRN) reported earnings 30 days ago. What's next for the stock?
